SBBP
Strongbridge Biopharma plc.
SBBP
SBBP
Delisted
SBBP was delisted on the 5th of October, 2021.
49 hedge funds and large institutions have $149M invested in Strongbridge Biopharma plc. in 2018 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 17 increasing their positions, 18 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
49
Holders Change
-15
Holders Change %
-23.44%
% of All Funds
1.12%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
8
Increased
17
Reduced
18
Closed
23
Calls
$39K
Puts
$11K
Net Calls
+$28K
Net Calls Change
+$28K
Top Buyers
| 1 |
CC
Caxton Corporation
Princeton,
New Jersey
|
+$4.35M |
| 2 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$2.45M |
| 3 |
PWAM
Park West Asset Management
San Francisco,
California
|
+$2.4M |
| 4 |
AC
Armistice Capital
New York
|
+$2.39M |
| 5 |
PM
Prosight Management
Dallas,
Texas
|
+$2.06M |
Top Sellers
| 1 |
LSC
Lyon Street Capital
Sausalito,
California
|
-$8.28M |
| 2 |
VC
Vivo Capital
Palo Alto,
California
|
-$4.85M |
| 3 |
PM
Precept Management
Dallas,
Texas
|
-$2.07M |
| 4 |
PA
Perceptive Advisors
New York
|
-$1.65M |
| 5 |
Goldman Sachs
New York
|
-$1.29M |
